Your browser doesn't support javascript.
loading
Genetic rearrangements, hotspot mutations, and microRNA expression in the progression of metastatic adenoid cystic carcinoma of the salivary gland.
Andreasen, Simon; Agander, Tina Klitmøller; Bjørndal, Kristine; Erentaite, Daiva; Heegaard, Steffen; Larsen, Stine R; Melchior, Linea Cecilie; Tan, Qihua; Ulhøi, Benedicte Parm; Wessel, Irene; Homøe, Preben.
Afiliación
  • Andreasen S; Department of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Køge, Denmark.
  • Agander TK; Department of Otorhinolaryngology Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen, Denmark.
  • Bjørndal K; Department of Pathology, Rigshospitalet, Copenhagen, Denmark.
  • Erentaite D; Department of Otorhinolaryngology, Head and Neck Surgery, Odense University Hospital, Odense, Denmark.
  • Heegaard S; Department of Pathology, Aalborg University Hospital, Aalborg, Denmark.
  • Larsen SR; Department of Pathology, Rigshospitalet, Copenhagen, Denmark.
  • Melchior LC; Department of Ophthalmology, Rigshospitalet-Glostrup, Copenhagen, Denmark.
  • Tan Q; Department of Pathology, Odense University Hospital, Odense, Denmark.
  • Ulhøi BP; Department of Pathology, Rigshospitalet, Copenhagen, Denmark.
  • Wessel I; Unit of Human Genetics, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Homøe P; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
Oncotarget ; 9(28): 19675-19687, 2018 Apr 13.
Article en En | MEDLINE | ID: mdl-29731974
ABSTRACT
Adenoid cystic carcinoma (ACC) is among the most common salivary gland malignancies, and is notorious for its unpredictable clinical course with frequent local recurrences and metastatic spread. However, the molecular mechanisms for metastatic spread are poorly understood. This malignancy is known to frequently harbor gene fusions involving MYB, MYBL1, and NFIB, and to have a low mutational burden. Most studies have focused on primary tumors to understand the biology of ACC, but this has not revealed a genetic cause for metastatic dissemination in the majority of cases. Hence, other molecular mechanisms are likely to be involved. Here, we characterize the genetic and microRNA expressional landscape of primary ACC and corresponding metastatic lesions from 11 patients. FISH demonstrated preservation of MYB aberrations between primary tumors and metastases, and targeted next-generation sequencing identified mutations exclusive for the metastatic lesions in 3/11 cases (27.3%). Global microRNA profiling identified several differentially expressed miRNAs between primary ACC and metastases as compared to normal salivary gland tissue. Interestingly, individual tumor pairs differed in miRNA profile, but there was no general difference between primary ACCs and metastases. Collectively, we show that MYB and NFIB aberrations are consistently preserved in ACC metastatic lesions, and that additional mutations included in the 50-gene hotspot panel used are infrequently acquired by the metastatic lesions. In contrast, tumor pairs differ in microRNA expression and our data suggest that they are heterogeneous according to their microRNA profile. This adds an additional layer to the complex process of ACC metastatic spread.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Dinamarca